Corcept TherapeuticsvsEli Lilly and Company

CORT and LLY stock compared: price, dividend, valuation and results, from SEC filings.

CORT

Corcept Therapeutics Incorporated

$69.22

Value $7.4B

-5.10%
CORT's page

LLY

Eli Lilly and Company

$1,431.67

Value $1.35T

-0.82%
LLY's page

Corcept Therapeutics (CORT) has a market value of $7.4B and Eli Lilly and Company (LLY) $1.35T. Over the last year, with dividends, CORT moved -8.4% and LLY +40.5%. The P/E is 46.2 for CORT and 49.0 for LLY. Dividend yield: CORT none, LLY 0.44%.

At a glance

The main figures of both. A bar only shows which number is larger, not which is better.

  • Market value

    CORT$7.4B

    LLY$1.35T

    LLY is 183 times CORT

  • Revenue, 12 months

    CORT$964M

    LLY$86.5B

    LLY is 90 times CORT

  • Net income, 12 months

    CORT$162M

    LLY$27.6B

    LLY is 170 times CORT

  • Operating margin

    CORT11.5%

    LLY–

  • ROIC

    CORT12.7%

    LLY35.5%

    22.8 points apart

  • P/E

    CORT46.2

    LLY49.0

    LLY is 1.1 times CORT

  • Dividend yield

    CORT0.0%

    LLY0.4%

    0.4 points apart

  • 5-year return

    CORT+202.4%

    LLY+478.4%

    276.0 points apart

A fainter bar means a negative number. The 5-year return includes dividends.

The price over time

Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.

CORT+202.4%

LLY+478.4%

20040060020222023202420252026
Returns by period
PeriodCORTWith dividendsLLYWith dividends
1 year since November 14, 2025-8.4%Price -8.4%+40.5%Price +39.6%
3 years since November 16, 2023+175.7%+40.2% a yearPrice +175.7%+148.1%+35.4% a yearPrice +143.2%
5 years since November 15, 2021+202.4%+24.8% a yearPrice +202.4%+478.4%+42.1% a yearPrice +454.0%
10 years since November 16, 2016+631.7%+22.0% a yearPrice +631.7%+2,064.5%+36.0% a yearPrice +1,760.8%

Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.

Every figure

As on each company's page. A description, not a recommendation: no one figure says which is better.

CORTCorcept TherapeuticsLLYEli Lilly and Company

Valuation

CORTLLY
Valuation
Price$69.22$1,431.67
Market value$7.4B$1.35T
Enterprise value (EV)$7.0B$1.40T
P/E46.249.0
P/E, 5-year median34.649.9
P/B8.833.5
EV/EBIT63.140.1
Free cash flow yield2.6%1.5%

Results and growth

CORTLLY
Results and growth
Revenue, 12 months$964M$86.5B
Net income, 12 months$162M$27.6B
Free cash flow, 12 months$195M$19.7B
Earnings per share, 12 months$1.50$30.81
Revenue growth, year on year12.8%44.7%
Revenue growth a year, past+16.6%over 5 years+21.6%over 5 years
EPS growth a year, past-0.7%over 5 years+27.6%over 5 years

Margins and returns on capital

CORTLLY
Margins and returns on capital
Gross margin98.5%83.6%
Operating margin11.5%–
Net margin16.8%31.9%
ROIC12.7%35.5%
ROE23.5%88.6%

Balance sheet

CORTLLY
Balance sheet
Cash$371M$4.9B
Total debt$9.0M$49.5B
Net debt / EBITDA-3.31.2
Interest cover–38.9×

Dividends and buybacks

CORTLLY
Dividends and buybacks
Dividend yield–0.4%
Dividend per share, 12 months–$6.34
Dividend growth a year, past–+15.2%over 5 years
Buyback yield2.4%0.3%
Shareholder yield2.4%0.7%

Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.

Questions: CORT or LLY

Didn't find what you were looking for?

Ask us
Which is bigger, Corcept Therapeutics or Eli Lilly and Company?

By market value, Eli Lilly and Company ($1.35T) is about 183.4 times Corcept Therapeutics ($7.4B), at today's prices.

How did CORT and LLY stock do over the last 10 years?

Since November 16, 2016, CORT's price moved +631.7% and LLY's +1,760.8%. With dividends: CORT +631.7% (+22.0% a year), LLY +2,064.5% (+36.0% a year). Past returns do not predict future ones.

Which pays the higher dividend, CORT or LLY?

The dividend yield at today's price is none for Corcept Therapeutics and 0.44% for Eli Lilly and Company. Over the last twelve months they paid – and $6.34 per share.

What is the P/E of CORT and LLY?

At today's price, the P/E is 46.2 for CORT and 49.0 for LLY. The median of the last five years was 34.6 and 49.9, which shows where each stands against its own past.

Which has the higher profit margins, Corcept Therapeutics or Eli Lilly and Company?

Over the last twelve months, the net margin was 16.8% for Corcept Therapeutics and 31.9% for Eli Lilly and Company, and the operating margin 11.5% and –. Revenue was $964M and $86.5B.

Which is the better investment, Corcept Therapeutics or Eli Lilly and Company?

The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.

Other comparisons

With each of the two, and with the largest in its sector.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

Descriptive data from SEC filings and market prices.